Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-020-02451-9.pdf
Reference6 articles.
1. Chou C-Y, Wang S-M, Liang C-C et al (2014) Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000000174
2. Sarnak MJ, Jaber BL (2001) Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120:1883–1887. https://doi.org/10.1378/chest.120.6.1883
3. Guan W-J, Ni Z-Y, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032
4. Liu Y, Yang Y, Zhang C et al (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374. https://doi.org/10.1007/s11427-020-1643-8
5. Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585
Cited by 436 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mortality prediction in Mexican older COVID-19 patients using the Charlson comorbidity index: a case- control study from a reconverted COVID-19 hospital;2024-07-19
2. Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records;PLOS ONE;2024-07-16
3. Unobvious long-term effects of COVID-19 for kidneys. The literature review;Nephrology (Saint-Petersburg);2024-07-12
4. Factors Associated with Prolonged SARS-CoV-2 Viral Positivity in an Italian Cohort of Hospitalized Patients;Diseases;2024-06-28
5. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3